Central Admixture Pharmacy Services, Inc. recalls succinylcholine 200 mg/10 mL (20 mg/mL), Syringe, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue
Recalled August 9, 2023 · FDA recall D-0949-2023 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility. Validation data for decontamination cycles is lacking. · FDA Class II
Units
26,208 Syringes
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Product
succinylcholine 200 mg/10 mL (20 mg/mL), Syringe, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue Pheonix, AZ, NDC 72196-6011-2.
Manufacturer(s)
Central Admixture Pharmacy Services, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →